1. Home
  2. DNTH vs SCVL Comparison

DNTH vs SCVL Comparison

Compare DNTH & SCVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • SCVL
  • Stock Information
  • Founded
  • DNTH 2015
  • SCVL 1978
  • Country
  • DNTH United States
  • SCVL United States
  • Employees
  • DNTH N/A
  • SCVL N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • SCVL Clothing/Shoe/Accessory Stores
  • Sector
  • DNTH Health Care
  • SCVL Consumer Discretionary
  • Exchange
  • DNTH Nasdaq
  • SCVL Nasdaq
  • Market Cap
  • DNTH 657.0M
  • SCVL 609.8M
  • IPO Year
  • DNTH N/A
  • SCVL 1993
  • Fundamental
  • Price
  • DNTH $19.59
  • SCVL $17.98
  • Analyst Decision
  • DNTH Strong Buy
  • SCVL Strong Buy
  • Analyst Count
  • DNTH 8
  • SCVL 1
  • Target Price
  • DNTH $54.33
  • SCVL $51.00
  • AVG Volume (30 Days)
  • DNTH 251.8K
  • SCVL 477.6K
  • Earning Date
  • DNTH 05-16-2025
  • SCVL 05-22-2025
  • Dividend Yield
  • DNTH N/A
  • SCVL 3.29%
  • EPS Growth
  • DNTH N/A
  • SCVL N/A
  • EPS
  • DNTH N/A
  • SCVL 2.68
  • Revenue
  • DNTH $6,235,000.00
  • SCVL $1,202,885,000.00
  • Revenue This Year
  • DNTH N/A
  • SCVL $1.17
  • Revenue Next Year
  • DNTH N/A
  • SCVL $4.11
  • P/E Ratio
  • DNTH N/A
  • SCVL $6.81
  • Revenue Growth
  • DNTH 120.63
  • SCVL 2.30
  • 52 Week Low
  • DNTH $13.37
  • SCVL $16.14
  • 52 Week High
  • DNTH $32.27
  • SCVL $46.92
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 45.90
  • SCVL 45.58
  • Support Level
  • DNTH $20.76
  • SCVL $17.08
  • Resistance Level
  • DNTH $22.14
  • SCVL $18.84
  • Average True Range (ATR)
  • DNTH 1.50
  • SCVL 0.78
  • MACD
  • DNTH -0.13
  • SCVL 0.24
  • Stochastic Oscillator
  • DNTH 5.53
  • SCVL 54.59

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. They operate their business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of our stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channel.

Share on Social Networks: